| Date Filed | Type | Description |
| 10/11/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2023 |
4
| ANDERSON JOSEPH B JR (Director) has filed a Form 4 on GENTEX CORP|
Txns:
| Sold 4,416 shares
@ $33.5243, valued at
$148k
|
|
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
8-K
| Quarterly results |
| 05/26/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/19/2023 |
4
| ANDERSON JOSEPH B JR (Director) has filed a Form 4 on GENTEX CORP|
Txns:
| Granted 4,716 shares
@ $0 |
|
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
3
| DEUR GARTH (Director) has filed a Form 3 on GENTEX CORP |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/02/2023 |
4
| Schaum Richard O (Director) has filed a Form 4 on GENTEX CORP|
Txns:
| Sold 5,424 shares
@ $27.8879, valued at
$151.3k
Exercised 12,000 options to buy
@ $12.365, valued at
$148.4k
|
|
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/06/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/07/2023 |
4
| Boehm Neil (Chief Technology Officer) has filed a Form 4 on GENTEX CORP|
Txns:
| Sold 1,242 shares
@ $28.41, valued at
$35.3k
Exercised 1,242 options to buy
@ $15.69, valued at
$19.5k
|
|
| 02/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/21/2023 |
4
| Ryan Scott P (General Counsel) has filed a Form 4 on GENTEX CORP|
Txns:
| Granted 6,666 shares
@ $0
Granted 5,570 shares
@ $0
Sold 5,570 shares
@ $28.2919, valued at
$157.6k
Sold 4,325 shares
@ $28.2919, valued at
$122.4k
|
|
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.2% stake in Gentex Corp. |
| 02/07/2023 |
8-K
| Other Events Interactive Data |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Nash Kevin C (CFO) has filed a Form 4 on GENTEX CORP|
Txns:
| Sold 6,776 shares
@ $29.4233, valued at
$199.4k
Exercised 6,776 options to buy
@ $14.7, valued at
$99.6k
|
|
| 01/27/2023 |
SC 13G/A
| BlackRock Inc. reports a 9.3% stake in GENTEX CORP |
| 01/27/2023 |
8-K
| Quarterly results |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/01/2022 |
4
| Wallace James H (Director) has filed a Form 4 on GENTEX CORP|
Txns:
| Sold 14,000 shares
@ $26.0391, valued at
$364.5k
Exercised 7,000 options to buy
@ $24.21, valued at
$169.5k
Exercised 7,000 options to buy
@ $18.7, valued at
$130.9k
|
|
| 10/31/2022 |
4
| Downing Steven R (President and CEO) has filed a Form 4 on GENTEX CORP|
Txns:
| Bought 10,000 shares
@ $25.74, valued at
$257.4k
|
|
| 10/28/2022 |
8-K
| Quarterly results |
|